Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Wafik El-Deiry shared a few must-reads paper on X:
Authors: Elizabeth Ding et al.
Authors: Oscar Maiques et al.
Characterization of single neurons reprogrammed by pancreatic cancer
Authors: Vera Thiel et al.
Functional analysis of cancer-associated germline risk variants
Authors: Laura N. Kellman et al.
Urinary DNA Methylation Test for Bladder Cancer Diagnosis
Authors: In Gab Jeong et al.
